CDNF, Potential DMT for Parkinson’s, May Work as Nasal Spray

A potential Parkinson’s  therapy based on a protein with an ability to protect neurons — called recombinant (lab-made) human cerebral dopamine neurotrophic factor (rhCDNF) — has been transformed into tiny nanoparticles that may allow for its use as a nasal spray, Herantis Pharma,…

Nasal Spray Seen as Easy and Effective Way to Deliver Glutathione, a Parkinson’s Therapy

A pilot study found that a nasal spray may be a promising and quickly effective way of delivering glutathione (GSH), and of increasing GSH levels in the brain of Parkinson’s disease (PD) patients. The study, “Central nervous system uptake of intranasal glutathione in Parkinson’s disease,” was published in the journal NPJ Parkinson’s…